NCT01837862 A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT01811992 Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma Status COMPLETED Phase PHASE1
NCT01811498 Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM Status COMPLETED Phase PHASE1/PHASE2
NCT01808820 Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma Status COMPLETED Phase PHASE1
NCT01800695 Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01777919 Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform Status NOT_YET_RECRUITING Phase PHASE2
NCT01756352 FET-PET for Evaluation of Response of Recurrent GBM to Avastin Status COMPLETED Phase PHASE2
NCT01752491 A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01631552 Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01618747 An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse Status COMPLETED Phase N/A
NCT01588769 A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients Status COMPLETED Phase PHASE1
NCT01587144 Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) Status TERMINATED Phase PHASE2
NCT01564914 A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma Status COMPLETED Phase PHASE2
NCT01562197 A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT01540513 PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404 Status COMPLETED Phase NA
NCT01526837 Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence Status TERMINATED Phase PHASE1